Description

3H-Pyrrolo[3,4-C]Pyridin-3-One,6-Ethyl-1,2-Dihydro-4-Methyl-2-(1-Methylethyl)-(9Ci) is a high-purity, advanced pharmaceutical intermediate belonging to the fused pyrrolopyridine class of heterocyclic compounds. This compound is valued for its complex molecular architecture, which serves as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly in the areas of oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of proprietary drug candidates targeting specific biological pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new chemical entities with improved efficacy and safety profiles.
• Oncology Drug Development: Serves as a core scaffold for constructing molecules designed to inhibit kinases or other enzymes involved in cancer cell proliferation.
• CNS-Active Compound Synthesis: Employed in the research and development of potential treatments for neurological and psychiatric conditions.
• Contract Research & Manufacturing (CRAM): Supplied to CDMOs for use in custom synthesis projects and process development for clinical trial materials.
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic synthesis and heterocyclic chemistry.

Basic Information

Item	Details
Product Name	3H-Pyrrolo[3,4-C]Pyridin-3-One,6-Ethyl-1,2-Dihydro-4-Methyl-2-(1-Methylethyl)-(9Ci)
CAS No.	444347-45-9
Molecular Formula	C13H18N2O
Molecular Weight	218.30 g/mol
Synonyms	6-Ethyl-1,2-dihydro-4-methyl-2-isopropyl-3H-pyrrolo[3,4-c]pyridin-3-one; 2-Isopropyl-6-ethyl-4-methyl-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one; 6-Ethyl-4-methyl-2-(propan-2-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one; 444347-45-9; Pyrrolo[3,4-c]pyridin-3-one derivative; Advanced heterocyclic intermediate
EINECS	Contact for details

Quality Control

Every batch of this pharmaceutical intermediate is produced under strict quality management systems to ensure consistency and traceability. Our products undergo rigorous quality testing, including advanced chromatographic and spectroscopic methods, to ensure compliance with the stringent requirements for advanced intermediates. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to support your regulatory and R&D documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The material should be kept under an inert atmosphere if long-term storage is required to prevent potential degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.